RLX Technology Inc. — FY2023 Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2023. This is an annual report, not a standalone Q4 filing; the filing does not provide a clear set of Q4-only financial results. Financial statements are prepared under U.S. GAAP. Amounts below are RMB unless otherwise noted; comparative 2021 and 2022 figures were retrospectively adjusted for acquisitions under common control.
Business context
RLX develops and sells e-vapor products, with China operations conducted through PRC subsidiaries and a consolidated variable interest entity (VIE) controlled through contractual arrangements. China sales run through licensed wholesale and retail channels and the national transaction platform. The company expanded internationally through acquisitions completed in December 2023; international revenue was RMB228.5 million.
Key financial metrics
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Net revenue | RMB1,586.4m (US$223.4m) | RMB5,332.8m | -70.3% |
| Gross profit / margin | RMB387.7m / 24.4% | RMB2,305.1m / 43.2% | Margin down 18.8 percentage points |
| Operating income (loss) | (RMB496.7m) | RMB1,063.4m | Turned to loss |
| Net income | RMB541.0m (US$76.2m) | RMB1,408.7m | -61.6% |
| Diluted EPS per ordinary share/ADS | RMB0.399 | RMB1.085 | Down |
| Operating cash flow | RMB198.7m (US$28.0m) | RMB486.8m | Down 59.2% |
| Cash, cash equivalents and restricted cash, year-end | RMB2,420.1m | RMB1,289.1m | Up |
| Total assets / total liabilities, year-end | RMB16,315.1m / RMB716.7m | RMB16,378.8m / RMB838.5m | Assets broadly stable; liabilities lower |
FY2023 interest income was RMB627.9m and investment income RMB245.7m, substantially supporting pretax income despite the operating loss. Adjusted net income, a non-GAAP measure excluding share-based compensation, was RMB903.9m versus GAAP net income of RMB541.0m. Share-based compensation was RMB362.9m.
Year-end liquidity included RMB2,631.3m of short-term bank deposits, RMB3,093.1m of short-term investments, RMB1,757.8m of long-term bank deposits, and RMB5,236.1m of long-term investment securities, in addition to cash and restricted cash. Management said these resources and expected operating cash flow should cover working capital and capital expenditure needs for the next 12 months. Total liabilities included RMB53.9m of lease liabilities; the filing reports no material long-term obligations or guarantees beyond disclosed commitments.
Material changes and unusual items
- Revenue fell 70.3%, mainly because older products were discontinued during the transition to China’s national standards; international expansion partly offset the decline. China revenue was RMB1,357.9m, while international revenue was RMB228.5m.
- Gross margin declined chiefly because of China’s 36% manufacturer excise tax, which contributed RMB342.4m of FY2023 expense. The tax took effect in November 2022.
- Operating expenses fell 28.8% to RMB884.4m, primarily reflecting lower salaries and welfare costs, but operating expenses equaled 55.8% of revenue.
- Investing cash flow was positive RMB2,091.1m, largely reflecting maturities of bank deposits and investments; financing cash flow was negative RMB1,193.2m, including RMB996.6m of share repurchases.
- RLX paid a cash dividend of US$0.01 per ordinary share/ADS in December 2023. The board extended the share repurchase authorization through December 31, 2025; approximately US$195.5m had been executed under the program as of year-end.
- December acquisitions of related-party businesses in North and Southeast Asia had total cash consideration of approximately US$24.4m and were accounted for as common-control transactions, with comparative periods retrospectively adjusted.
Outlook, risks and contingencies
- No quantified revenue, earnings or margin guidance is provided. Management describes international expansion as a strategy but cautions that execution, local regulation, supply chains and integration create risks.
- China regulation remains a major business risk: flavored products other than tobacco flavor, online sales, and many advertising and promotion channels are prohibited or restricted. Manufacturing licenses disclosed in the filing are valid through June or July 2025; retail stores and suppliers also require continuing licenses and approvals.
- RLX depends on contractual VIE arrangements rather than equity ownership of its principal China operating entity. Their enforceability has not been tested in court, and regulatory action could disrupt operations or investor access to VIE economics.
- Production and supplier concentration are significant: one manufacturer accounted for 58% of purchases and 74% of accounts and notes payable in 2023. The company also disclosed that its exclusive production plants were not in strict compliance with environmental inspections and regulations based on its knowledge, despite improvement during 2023.
- Cash and earnings are exposed to investment returns, credit and interest-rate risks; the filing notes substantial cash and investments held in China and restrictions on transfers and dividend remittances. The VIE held 38.8% of cash, cash equivalents and restricted cash at year-end.
- The company believes it was likely a PFIC for U.S. tax purposes in 2023 and may be one in 2024. PCAOB inspection access to China-based auditors was restored in 2022, but future loss of access could revive HFCAA trading-prohibition risk.
- The securities class action concerning the IPO disclosures was dismissed with prejudice; the Second Circuit affirmed the dismissal in November 2023. The filing says the company is not party to other material legal proceedings.
- Management and the auditor concluded internal control over financial reporting was effective at year-end. However, 12 acquired entities, representing 14% of consolidated revenue, were excluded from the assessment and audit of internal controls.
Most important facts for investors to verify
- Whether the sharp revenue decline stabilizes, and whether international sales can offset contraction in China.
- The ongoing impact of excise tax, product restrictions, license capacity and distributor access on realized gross margins and sales.
- Cash-flow conversion and the liquidity, maturity, credit quality and accessibility of the company’s bank deposits and investment securities.
- Progress in renewing licenses, resolving production-plant environmental compliance issues, and reducing dependence on concentrated suppliers.
- Acquisition performance, related-party dealings, and the integration and internal-control coverage of acquired businesses.
- VIE enforceability, PRC approval or filing requirements for future capital raising, and the ability to transfer funds from China.
- Future share repurchases and dividends, including the effect on cash resources, and the company’s PFIC status for U.S. investors.